Cure SMA Cure SMA Cure SMA

We can see a future without SMA.

SMA is the number one genetic cause of death for infants. But together, we're making real progress toward a treatment and cure.

Learn MoreLearn More

Together, We Can Cure SMA

Cure SMA is our name, and it’s also our rallying cry. Show our collective strength, united to cure SMA

Learn More

New Research Funding Announced

Cure SMA will be committing $1.8 million to new research funding over the next year.

Learn More

Cure SMA Reaches Out to Newly Diagnosed Families

While we work toward a cure for SMA, we're also working to improve quality of life for families today. Newly diagnosed care packages and conference scholarships are part of that pledge.

Learn More

Cure SMA Updates

Cure SMA Researchers Present at Society for Neuroscience Meeting

Cure SMA Researchers Present at Society for Neuroscience Meeting

PTC Therapeutics Announces New Phase 1a/2b Clinical Trial

PTC Therapeutics, Inc. announced today that its joint development program in Spinal Muscular Atrophy (SMA) with Roche and the SMA Foundation (SMAF) has...

READ MORE

PTC Therapeutics, Inc. announced today that its joint development program in Spinal Muscular Atrophy (SMA) with Roche and the SMA Foundation (SMAF) has...

READ MORE

Isis Announces Second Phase III Clinical Trial

Isis recently announced the start of CHERISH, a multi-center Phase III clinical study evaluating the efficacy and safety of the investigational compound, ISIS-SMNRx, in non-ambulatory children with Spinal Muscular Atrophy (SMA). The study is a...

READ MORE

Isis recently announced the start of CHERISH, a multi-center Phase III clinical study evaluating the efficacy and safety of the investigational compound, ISIS-SMNRx, in non-ambulatory children with Spinal Muscular Atrophy (SMA). The study is a...

READ MORE

© 2014 Cure SMA | Privacy Policy

Powered by Convio
nonprofit software